Skip to content

Released May 12, 2020, after the close

10-Q filed May 13, 2020, 43 days after period end · 0001636422-20-000049

Q1 2020 · 10-Q
Revenue$45.12M+28.1% vs Q1 2019+3.7% vs Q4 2019
Net Income-$17.49MN/M vs Q1 2019N/M vs Q4 2019
EPS Diluted-$0.47N/M vs Q1 2019no prior Q4 2019 on file
Operating Income-$18,105,000N/M
Operating Cash Flow-$16,769,000N/M
Free Cash Flowderived-$17,197,000N/M
Margins · derived
Operating margin-40.1%−8.6 pt vs Q1 2019
Net margin-38.8%+0.2 pt vs Q1 2019

What the release said

The release

Same quarter

MetricQ1 2020Q1 2019
Revenue$45.12M$35.21M
Net Income-$17.49M-$13.72M
EPS Diluted-$0.47-$16.21

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR